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Abstract 
Aim: 
Case fatality rates for child severe malnutrition have remained high globally and in South Africa. It 
has been postulated that much of this excess mortality is due to HIV infection. This study sought to 
examine case fatality rates in children with and without HIV infection, and with different forms of 
malnutrition. 
Methods: 
A prospective, observational study was undertaken at three academic hospitals in Johannesburg, 
South Africa. Severely malnourished children were identified and their anthropometric details, 
clinical features, laboratory findings and admission outcomes analysed. Nutritional status was 
categorised using the Wellcome and WHO classifications. All children had their HIV status 
established. 
Results: 
The case fatality rate in 113 severely malnourished children was 11.5%. Fifty one percent of children 
were HIV infected. Most (44%) of children had kwashiorkor, with 26% having marasmus and 20% 
classified as marasmic kwashiorkor. HIV positive children were significantly more likely to die than 
negative children (19% vs 3.6%, OR 6.2, 95% CI 1.2–59, p=0.02). Marasmic children were more likely 
to have HIV than those with kwashiorkor or marasmic kwashiorkor (83% vs 33%, OR 9.7, 95% CI 3.5–
29.1, p< 0.001). Half (51%) of all HIV negative children whose mother’s status was known had an HIV 
positive mother. TB was suspected and treated in 24% of children, although confirmed in only 19% 
of these. Factors associated with an increased mortality included hypothermia (OR 9.7), 
hypoglycaemia (OR 9.7), shock (OR 7.2), thrombocytopaenia (OR 5.7), raised INR (OR 9.8) and the 
intravenous administration of fresh frozen plasma or packed red blood cells (OR 9.7 and 7.8 
respectively). 
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Conclusion: 
The HIV pandemic has altered the face of malnutrition in the study setting. Case fatality rates remain 
unacceptably high in HIV positive malnourished children. Specific guidelines for the management of 
severe malnutrition in HIV positive children and improved tuberculosis, growth monitoring and 
growth promotion programmes could reduce this impact.  
vii 
 
Acknowledgements 
 
I wish to thank my supervisor, Prof Haroon Saloojee, whose encouragement, knowledge and 
experience were instrumental in reaching the stage when this document will be printed. His 
dedication and time despite countless other commitments are much appreciated.  
viii 
 
Table of contents 
 Page 
DECLARATION 
DEDICATION 
PUBLICATIONS AND PRESENTATIONS 
ABSTRACT 
ACKNOWLEDGEMENTS 
TABLE OF CONTENTS 
LIST OF FIGURES 
LIST OF TABLES 
ii 
iii 
iv 
v 
vii 
viii 
x 
xi 
1. BACKGROUND 1 
1.1 Setting the scene 
1.2 Classification of malnutrition 
1.3 HIV/AIDS 
1.4 Case fatality rates 
1.5 Direct causes of death 
1.6 Prognostic factors 
1.7 Infections and malnutrition 
1.8 Justification for this study 
1 
3 
3 
4 
5 
6 
6 
7 
2. METHODS 8 
2.1 Definitions 
2.2 Study hypothesis 
2.3 Objectives 
2.4 Study design 
2.5 Study setting 
2.6 Study sample 
2.7 Measuring tools 
2.8 Patient management 
2.9 Data capture and statistical analysis 
2.10 Ethical considerations 
2.11 Finance 
8 
8 
8 
8 
9 
9 
9 
12 
13 
13 
13 
3. RESULTS 14 
3.1 General characteristics 
3.2 History 
3.3 Clinical features 
3.4 Laboratory results 
3.5 Infections 
3.6 Patient management 
3.7 Outcomes 
3.8 Poor prognostic factors 
3.9 Causes of death 
3.10 HIV status 
3.11 The HIV “affected” children 
14 
17 
19 
21 
22 
24 
25 
27 
27 
29 
30 
4. DISCUSSION 31 
4.1 Main findings 
4.2 General characteristics 
4.3 Clinical presentation and laboratory features 
4.4 Infections 
4.5 Patient management 
4.6 Outcomes 
31 
32 
34 
35 
36 
39 
ix 
 
 Page 
4.7 Prognostic factors and direct causes of death 
4.8 HIV infected children 
4.9 HIV affected children 
4.10 Study limitations  
4.11 Areas for future research 
40 
42 
43 
44 
46 
5. CONCLUSION 47 
6. RECOMMENDATIONS 49 
7. REFERENCES 50 
APPENDIX A – Questionnaire  56 
APPENDIX B – Ethical approval 60 
APPENDIX C – Gauteng Department of Health approval 61 
 
 
 
  
x 
 
List of figures 
Figure Page 
Figure 3.1 Age distribution in months of severely malnourished children 15 
Figure 3.2 Prevalence of WHO criteria for severe malnutrition in different Wellcome 
classes. 
15 
Figure 3.3 Survival of hospitalised severely malnourished children during the first four 
weeks after admission according to HIV status. 
26 
Figure 3.4 Duration of antiretroviral therapy in HIV infected children prior to admission 29 
 
 
 
  
xi 
 
List of tables 
Table Page 
Table 1.1 The Wellcome classification of severe malnutrition 3 
Table 3.1 WHO criteria for severe malnutrition compared to other signs/criteria 16 
Table 3.2 HIV infection rates in different types of malnutrition 16 
Table 3.3 Presenting complaints according to type of malnutrition 18 
Table 3.4 Child’s breastfeeding status according to child and mother’s HIV infection status 19 
Table 3.5 Clinical signs classified by Wellcome classification status 20 
Table 3.6 Clinical signs classified by HIV status 20 
Table 3.7 Laboratory investigations classified by Wellcome classification status 21 
Table 3.8 Organisms cultured from blood in children with severe acute malnutrition 23 
Table 3.9 TB treatment according to malnutrition type and HIV status 24 
Table 3.10 Administration of vitamins and minerals in children with severe acute 
malnutrition 
25 
Table 3.11 Mortality of severe malnutrition according to type of malnutrition and HIV 
status 
26 
Table 3.12 Poor prognostic factors for all severe malnutrition and kwashiorkor 
(oedematous malnutrition) deaths 
28 
Table 3.13 Differences between HIV positive, HIV exposed but negative (“HIV affected”) 
and HIV non-exposed children 
30 
 
 
  
1 
 
1. Background 
1.1. Setting the scene 
Childhood malnutrition and more specifically, undernutrition, is a public health problem as old 
as time. Little is known about the prevalence and mortality of severe malnutrition before the 19th 
century, perhaps because it was so common that it was seen as a normal part of life. Despite the 
enormous progress made by humanity since then, malnutrition remains rife in many parts of the 
world.(1) 
Globally, this disease remains an important cause of death in children under five years of age. 
Recently, mathematical models have estimated that more than half of all deaths in children 
worldwide are related to undernutrition (defined as weight one or more standard deviations below 
expected for that age when compared to an international reference population).(2) In this context, 
poor nutrition has been shown to increase a child’s risk of dying due to diarrhoea, pneumonia, 
measles, malaria and other infectious diseases. Being underweight and the associated micronutrient 
deficiencies affect the host’s immune and non-immune defences, and this makes the child more 
likely to suffer life threatening infections.  
Apart from undernutrition contributing to such a large proportion of deaths in children under 
five, severe malnutrition is a well recognised main cause of death in children in this age group. The 
disease carries a high (20-60%) case fatality rate in some settings and has been a focus of several 
World Health Organization (WHO) initiatives to improve its prognosis.(3, 4) In South Africa, the 
Medical Research Council carried out studies in 2000 to estimate the burden of disease profile for 
different age groups. Severe malnutrition ranked as the number five cause of death for all children 
under five years of age.(5) In rural areas the problem is even larger, as is shown in the annual census 
data from Agincourt in Limpopo, where malnutrition remains among the top four causes of death in 
the same age group.(6) 
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The seriousness of the situation in South Africa has recently been highlighted by the 2005 
National Food Consumption Survey. While stunting (height for age greater than two standard 
deviations below expected) remains the most prevalent form of undernutrition, occurring in 23.4% 
of children aged one to three years, the rates of underweight (weight for age greater than two 
standard deviations below the mean) and wasting (weight for height greater than two standard 
deviations below the mean) are also unacceptably high occurring in 11% and 5.2% respectively of all 
South African children aged one to three years. Although the survey found that most growth 
parameters measured had improved slightly from those found in the 1999 National Food 
Consumption Survey, it is of particular concern that there has been a statistically significant increase 
in the prevalence of wasting and severe wasting (weight for height greater than three standard 
deviations below the mean) in urban areas. The authors suggest that an accelerated rate of 
urbanisation may be partially responsible but assert that the impact of the Human 
Immunodeficiency Virus (HIV) pandemic must be examined closely.(7) 
Malnutrition has been highlighted by the United Nation’s Millennium Development Goal (MDG) 
initiative.(8) This initiative has set eight broad goals with 2015 as a target date, hoping to bring 
improvement in key areas in health, education, environmental concerns and social development. 
The first MDG is to halve the amount of people suffering from hunger and poverty between 1990 
and the year 2015. Similarly, the fourth MDG is to reduce under-five mortality by two thirds in the 
same time period.(8) The United Nations 2008 MDG progress report describes how rising food prices 
are one of the major factors limiting the global ability to achieve the first goal. Sub-Saharan Africa is 
identified as having made little or no progress towards goal 4 - reducing child mortality.(9) 
In South Africa, a double burden of malnutrition has been described: there is obesity which leads 
to diseases such as diabetes mellitus and hypertension in adults on the one extreme, and there 
exists a large burden of undernutrition on the other extreme.(10) 
3 
 
1.2. Classification of malnutrition 
Many different classifications of severe malnutrition have been used.(11) Perhaps the most 
commonly used is the WHO classification, which primarily uses wasting as an indicator of severe 
disease.(12, 13) It includes children with a weight for height z-score of -3 or less, a mid-upper arm 
circumference of less than 11.5 cm or the clinical criteria of severe visible wasting or bipedal 
oedema. In South Africa, most health centres still prefer to use the Wellcome classification.(14) In this 
system, marasmus, kwashiorkor, and marasmic kwashiorkor may be classed as severe malnutrition. 
Table 1.1 illustrates this classification. In practice, the WHO definition is slightly broader, and more 
children will be identified as having severe malnutrition if one uses this definition. While the 
management of these additional patients classified as severe malnutrition using the WHO definition 
carries little risk and is likely to be beneficial, resources and economic constraints may discourage 
the use of a less discriminate definition. 
Table 1.1 The Wellcome classification of severe malnutrition(14) 
 No oedema Oedema 
60-80% expected 
weight for age 
Underweight Kwashiorkor 
<60% expected 
weight for age 
Marasmus Marasmic kwashiorkor 
 
1.3. HIV/AIDS 
The HIV pandemic is thought to be largely responsible for the halted decline in malnutrition 
rates in South/ern Africa.(7) Sanitation and household food security have improved in urban South 
African settings (15) and secondary malnutrition (owing to a defined medical or surgical condition) 
may be obscuring an absolute decline of children with primary malnutrition. This is similar to 
patterns described in the West Indies in the last decade of the 20th century.(16) Over the last two 
decades, African studies have described prevalence rates of HIV infection in severely malnourished 
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children ranging from 13.8% to 48.6%.(17-19) Although limited data are available about the situation in 
South Africa, HIV is likely to be a significant contributor in view of the infection’s high prevalence 
here.(20) 
Failure to thrive is a well described feature of paediatric HIV infection, and due to a vicious cycle 
of immune dysfunction, infections and malnutrition, these children are vulnerable to both the 
oedematous and non oedematous forms of the disease.(21) Nevertheless, traditional risk factors for 
developing severe malnutrition such as poor social circumstances and food insecurity still play an 
important role.(22)  
Despite progress made in the Prevention of Mother to Child Transmission (PMTCT) of HIV 
programme, a large number of South African HIV positive infants remain undiagnosed until they are 
symptomatic. Many infants are already severely malnourished by the time they first present to the 
health services. They are at a high risk of dying from overwhelming infections in the course of their 
first hospital admission.(23) Additionally, the recent CHER study in South Africa showed that all infants 
with HIV should be started on highly active antiretroviral therapy (HAART), as soon as possible after 
diagnosis and that this reduces mortality significantly.(24) It is clear that South Africa and other 
African countries need to strengthen their PMTCT and infant diagnosis and treatment programmes if 
they are to stand a chance to reduce infant and under-five mortality and severe malnutrition rates. 
1.4. Case fatality rates 
In 1996, a seminal literature review was published by Ashworth in the Bulletin of the World 
Health Organization on the persistently high mortality rates seen across the world.(25) Mortality rates 
remained at 20-30% for all children admitted with severe malnutrition, but were even higher (50-
60% in some places) for the oedematous forms of malnutrition.(25) Inadequate case management 
and conflicting guidelines were identified as potential causes for this high case fatality and hence the 
WHO guidelines were conceived.(3, 4)  
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The WHO manuals are aimed at doctors and primary health care workers and provide mainly 
evidence based principles and guidelines to adequately treat severely malnourished children. The 
original aim was to decrease the case fatality rates of severe malnutrition to below five percent. This 
target has been achieved in several settings, although these settings were mainly dealing with acute 
starvation situations or had a low HIV prevalence.(26) The WHO guidelines were tested in two rural 
settings in South Africa and although they were able to decrease mortality to 18% at both sites, the 
five percent target remained elusive.(27, 28) It was hypothesised that the excess mortality was largely 
due to HIV.  
This was shown to be the case recently in a prospective cohort study from Malawi where 
children with severe malnutrition were followed up for four months after discharge from hospital. 
The observed mortality rate was 35.4% in the HIV positive children, versus 10.4% in HIV uninfected 
children (p<0.001). The highest mortality rate (40%) was seen in children with a CD4 count of less 
than 20%.(29) 
 
1.5. Direct causes of death 
The common direct causes of death and poor outcome, and steps to prevent them, are 
addressed extensively in the WHO “10 steps” to manage severe malnutrition guidelines.(3) These 
include the prevention and treatment of hypoglycaemia, hypothermia, dehydration, electrolyte 
abnormalities and infections. They also expand on the treatment of shock, septic shock and severe 
anaemia while carefully avoiding fluid overload in these acutely ill patients. Another point that is 
emphasised is the provision of a somewhat calorie and protein restricted diet (F75) in the early days 
of admission, as it is thought that the child will be unable to cope with the extra metabolic stress of a 
richer diet.(25) While these are all well accepted and researched management principles, the “10 
Steps” protocol is not widely practised in the hospitals participating in the current study. In these 
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Johannesburg hospitals, all severely malnourished children are managed by a team that is 
nevertheless experienced in the care of severely malnourished children and each child’s care is 
supervised by paediatricians and dieticians.  
1.6. Prognostic factors 
In view of the high case fatality rate experienced, several studies have attempted to establish 
poor prognostic features. One of the first studies was done at Baragwanath Hospital in 1959, and its 
results are still often quoted on paediatric ward rounds in this hospital.(30) From these early 
observations, generations of students have been taught a mnemonic (WEEPJIPHHH) to help 
remember some of these features. “WEEPJIPHHH” stands for Weeping dermatitis, Enlarged liver (>4 
cm), Eye ulcerations, Petechiae, Jaundice, Infection, Pallor, Hypoglycaemia, Hypothermia and 
Hypokalaemia.  The prognostic validity of these findings in the present high HIV prevalence setting 
has not been tested, and it seems unlikely that they still carry the same implications as 50 years ago. 
Several more recent studies have looked at poor prognostic features since then, and although there 
is little consensus within them, the following feature frequently: severe dehydration, severe acidosis, 
electrolyte imbalances and the administration of intravenous infusions of blood or fluid.(31-33) In 
particular, Maitland and colleagues published a large, retrospective data set which showed that the 
WHO danger signs (lethargy, hypothermia and hypoglycaemia), brady cardia, prolonged capillary 
refill time > 2 sec, a weak pulse and impaired level of consciousness were the most significant 
predictors of death in their multivariate analysis.(31) 
1.7. Infections and malnutrition 
Infections are an important part of the vicious circle in severe childhood malnutrition.(34) While 
this review has already described the relationship between HIV and malnutrition (see section 1.3), 
there are several other infections which are pertinent. Concurrent with the HIV pandemic, 
tuberculosis (TB) has become a more frequently found illness in children, owing to both increased 
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exposure from infected adults and the immune paresis present in children infected with HIV.(35) 
While TB has traditionally been very difficult to diagnose in children, it is even more challenging in 
children with HIV and/or malnutrition, with both diseases diminishing the tuberculin skin test 
response.(36, 37) In addition, distinguishing TB disease from TB infection is difficult and often based on 
clinical signs and symptoms which overlap with those of HIV. It is therefore of paramount 
importance that basics such as contact tracing and isoniazid prophylaxis are practised routinely.  
While TB and HIV can both cause childhood malnutrition, many other infections are often as an 
indirect result of malnutrition. The immune dysfunction that results from poor nutrition has been 
studied extensively over the last 50 years.(38) In children with severe malnutrition, high prevalences 
of bacteraemia (12-22%), urinary tract infections (8-35%), gastroenteritis (27-71%), pneumonia (26-
38%) and nosocomial infections (21-49%) have been described.(39-45) These infections are in fact so 
common that the WHO guidelines recommend the routine administration of broad spectrum 
antibiotics to all severely malnourished children.  
1.8 Justification for this study 
This research project is unique primarily because of its setting: the outcome of severe 
malnutrition has not been studied in a resource privileged but high HIV prevalence setting such as 
the academic hospitals in Gauteng. The project also explores the relationship of this outcome to the 
type of malnutrition (kwashiorkor or marasmus) and HIV status.  
Other aims include the opportunity to look at the prevalence of infections in malnourished 
children infected with HIV, and where possible to look for direct causes of death. Additionally, this 
research provides an opportunity to examine poor prognostic factors for this group of children. 
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2. Methods: 
2.1. Definitions  
Children were defined as having severe malnutrition if they fulfilled the World Health 
Organization (WHO) or the Wellcome classification criteria. (See section 1.2 and Table 1.1)  
2.2. Study hypothesis 
Severely malnourished children who are infected by HIV have a poorer outcome than their HIV 
negative counterparts, and the WHO target case fatality rate of less than 5% may be unrealistic in a 
high HIV prevalence setting. 
2.3. Objectives 
Primary objective: 
 To determine in-hospital case fatality rates for children with severe malnutrition 
admitted to academic hospitals in Johannesburg, and compare the outcomes of HIV 
positive and negative children 
Secondary objectives: 
 To compare case fatality rates in different types of malnutrition: kwashiorkor, marasmus 
and marasmic kwashiorkor 
 To identify poor prognostic factors in the different malnutrition groups 
 To  establish direct causes of death where possible 
 To determine the prevalence of bacterial  infections in this population 
2.4. Study design 
A prospective, observational study design was used.  
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2.5. Study setting 
The study was conducted at three academic hospitals in Johannesburg: the Charlotte Maxeke 
Johannesburg Academic Hospital (formerly Johannesburg General Hospital), the Chris Hani 
Baragwanath Hospital and the Rahima Moosa Mother and Child Hospital (formerly Coronation 
Hospital).  
2.6. Study sample 
An attempt was made to enrol all children admitted to any of the above hospitals between 4 
September and 30 November 2008. Inclusion criteria were an age of less than 60 months and a 
diagnosis of severe malnutrition.  
An ideal sample size was calculated using an estimated case fatality rate of 5% in HIV negative 
children and 15% in HIV positives, assuming that 50% of patients with severe malnutrition would be 
HIV positive. Using Epi Info 3.4.1 (CDC, Georgia, USA), a sample size of 318 patients would be needed 
to show a statistical difference in mortality of 10%, with 95% confidence (p-value <0.05) and a study 
power of 80%. However, in view of the time limit for this projects’ data gathering, it was decided to 
enrol as many patients as possible in the available time, and continue even if the ideal sample size 
was not achieved. 
2.7. Measuring tools 
2.7.1. Identification and enrolment 
Paediatric registrars who worked in any of the three hospitals’ admission wards were asked to 
identify potential participants on hospital admission, and to get informed consent from the child’s 
caregiver for enrolment in the study. This was done to maximise enrolment and avoid the difficulties 
in obtaining consent at a later stage (when the caregiver may no longer be present) or in case the 
child died soon after admission. 
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2.7.2. Measurements 
The researcher visited each hospital at least twice a week to gather data on all newly and 
previously enrolled participants. The first weight recorded on hospital admission was used as a 
patient may have lost weight owing to resolution of oedema by the time the researcher visited 
them. Length was measured by the researcher with a foldable, measuring board on which the child 
could lie. Recumbent length was used unless the child was over the age of two years and able to 
stand. The measuring board was laid flat on the child’s bed and straightened. The child was then 
placed on top with his or her head against the head piece of the board. The child’s head was put in a 
neutral position and the length was read at the bottom of the feet to the nearest millimetre. 
Occipitofrontal head circumference and mid-upper arm circumference (MUAC) were measured by 
the researcher with a tape measure to the nearest millimetre. MUAC measurements can be used as 
a marker for wasting. Since this measurement changes little during the first few years of life, 11.5 cm 
has been used as a cut-off value for children between six months and five years.(12) Anyone who has 
a lower MUAC is likely to be severely wasted. Occipitofrontal diameter was measured extending the 
tape from the most prominent part of the occiput and across the forehead just above the glabella. 
Mid-upper arm circumference was measured at the midpoint between the acromium and the lateral 
epicondyle of the humerus. Both the measurements obtained from the patient record (as done by 
the admitting doctor, usually by means of a tape measure) and those by the researcher were 
captured and compared. The researcher’s measurements (or the ward doctors’ measurements if not 
measured by the researcher) were converted to z-scores using the WHO Anthro software (available 
from http://www.who.int/childgrowth/),(46) using the WHO reference values.(47)  
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2.7.3. Study data sheet 
A detailed, 155-item study data sheet was completed by the researcher for each participant 
(Appendix A). The data sheet included data about anthropometrics, HIV status, presenting 
complaints, additional history, vital signs and examination findings, laboratory results, patient 
management and the outcome of the admission. The history was primarily obtained from the file, 
but if the caregiver was present at the time the researcher was visiting the child, the researcher 
verified information and asked further details. In the majority of cases this was not possible. The 
information in the file was not always complete. Data on feeding practices and social history 
especially were scant, and little inference could be drawn from these as a result. Examination 
findings were also obtained from the file and then verified by a brief examination conducted by the 
researcher.  
2.7.4 Definitions 
Shock was defined clinically as a prolonged capillary refill time (>3 sec), cold peripheries or low 
blood pressure for age. Hypothermia was defined as a core body temperature of less than 35 C̊. 
Respiratory distress was defined as tachypnoea (for age), alar flaring, chest recessions or the use of 
accessory muscles. Lymphadenopathy was defined as lymph nodes larger than 0.5 cm. Staining the 
eyes with fluorescein to identify corneal ulcers was done by the attending doctors.  
Laboratory results were obtained from the various National Health Laboratory Services (NHLS) 
computer systems at each of the hospitals. Urinary tract infection was defined as the presence of 
more than 106 organisms/ml of fresh urine, more than 103 per ml of suprapubically aspirated urine, 
or a positive urine culture (excluding skin contaminants). 
2.7.5 Outcomes 
The researcher briefly saw each child on subsequent visits to identify any further changes in the 
child’s condition and management. The outcome for each child was captured as one of three 
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categories: discharged, died, or transferred to a recuperative care hospital (Selby Park Hospital) 
when stable. In cases of death, the immediate cause of death and the Child Health Problem 
Identification Programme (CHIP) data form was captured. While it was not possible in this study to 
identify the direct cause of death in all patients, an attempt was made to identify this from 
examining the ward notes, death certificates and, where available, Child Health Problem 
Identification Programme (CHIP) forms. Unfortunately, only one of the three hospitals was using the 
CHIP audit system at the time of the study. Selby Park Hospital was visited to examine whether any 
further complications or death occurred to children while admitted there. The results of cultures for 
Mycobacterium tuberculosis species from blood and sputum were reviewed at a later date. 
2.8. Patient management 
Patients were managed by the attending ward doctors as per the existing ward protocols or 
guidelines. In this setting, the patient is seen daily by a medical intern or medical officer as well as a 
paediatric registrar. He or she in turn is guided by a specialist paediatrician. Although no written 
protocols are followed for managing severe malnutrition, broad management principles are similar 
to those set out in the WHO’s “10 step” protocol. The areas where the local study site management 
differed significantly from the WHO guidelines included the lack of provision of F75 and F100 feeds 
and mineral supplements. Criteria for blood transfusions and intravenous fluids are also not as strict 
as in the WHO manual, and these decisions are made by the attending registrars and consultants.  
Routine investigations done on all severely malnourished children included: a full blood count, 
urea and electrolytes, liver function test, clotting profile (INR), blood culture, C-reactive protein and 
a urine dipstix and culture. HIV status was confirmed in children under 18 months using a HIV 
polymerase chain reaction test (PCR) or by use of an HIV ELISA in children over 18 months of age. 
Induced sputum or gastric washings for TB microscopy and culture were performed when TB was 
suspected. Analysis of these specimens was done by the National Health Laboratory Service that 
served the three hospitals. Discharge criteria and down-referral criteria for patients varied, but 
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generally patients were expected to show two consecutive weight gains before discharge and had to 
be stable and have lost all oedema (if present) before down-referral. 
2.9. Data capture and statistical analysis 
A database was designed in Microsoft Office Access 2007 (Microsoft, Seattle, USA) by the 
researcher. Data were entered and data cleaning was also done using this software. Data analysis 
was done using SPSS 15 (SPSS Inc, Chicago, USA) and Intercooled Stata 7.0 (Stata Corp., College 
Station, Texas, USA). Graphs were produced using SPSS 15 and Microsoft Office Excel 2007 
(Microsoft, Seattle, USA). Comparison of means was done using the student’s t-test for parametric 
data, and bivariate analysis using the chi-square test. Comparison of medians for non-parametric 
data was done using the Mann-Whitney test, and survival analysis using the log rank test. Visual 
inspection of histograms, and Shapiro-Wilk tests confirmed which continuous variables followed a 
normal distribution. Odds ratios (OR), standard deviations (SD), interquartile ranges (IQR) and 95% 
confidence intervals (95% CI) are specified where applicable. A p-value < 0.05 was considered 
statistically significant. 
2.10. Ethical considerations 
Data capture sheets did not contain names, hospital numbers or any other information that 
could identify the participants. A unique study number was used as a key to link the data capture 
sheets to the participant’s information. Ethical approval was obtained from the Committee for 
Research in Human Subjects at the University of the Witwatersrand (Medical) (Protocol number 
M080809) (Appendix B). Permission was also obtained from the Gauteng Department of Health and 
the medical superintendents at the various hospitals (Appendix C). 
2.11. Finance: 
Funding was received from the Faculty of Health Sciences’ Faculty Research Committee.  
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3. Results 
3.1. General characteristics 
One hundred and fifteen children were enrolled. Two children were later excluded. Both were 
initially considered to have kwashiorkor, but the first child was reclassified as a nephrotic syndrome 
and the second as an HIV associated nephropathy.  
Of the remaining 113 patients, 55 (49%) were female. The patient contribution of the various 
hospitals was as follows: 24 (21%) from Charlotte Maxeke Johannesburg Academic Hospital, 44 
(39%) from Rahima Moosa Mother and Child Hospital and 45 (40%) from Chris Hani Baragwanath 
Hospital.  
The median age of the children was 10 months (interquartile range [IQR] 5-17 months), with a 
range of 1 to 34 months (Figure 3.1). Fifty-eight children tested HIV positive (51%), while 55 were 
HIV negative (49%). Within the HIV negative group, 19 (35%) children had a HIV positive mother, 18 
(33%) a HIV negative mother, and in 18 (33%) cases the mother’s HIV status was unknown.  
Classification of Malnutrition 
All patients who fulfilled the Wellcome criteria also met the WHO criteria. Every child that 
qualified according to the WHO criteria did so with significant wasting (weight for length z-score less 
than -3), a MUAC of less than 11.5cm or bipedal oedema (see figure 3.2). Eight children (7%) who 
met the WHO definition for severe malnutrition did not meet the Wellcome classification criteria. 
Four of the eight had bipedal oedema but their weight was more than 80% of expected weight for 
age, while a further four were severely wasted (weight for length Z-score < -3), but their weight was 
not less than 60% of expected for their age (see Table 3.1). For further analysis, the first four 
children have been reclassified as having kwashiorkor, the latter four as marasmic. 
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Figure 3.1 Age distribution in months of severely malnourished children (N=113) 
 
Figure 3.2 Prevalence of WHO criteria for severe malnutrition in different Wellcome classes. 
(N=113) 
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Table 3.1 WHO criteria for severe malnutrition compared to other signs/criteria (N=113) 
 Weight for 
Age Z-score < 
-3 
Weight for 
length Z-
score < -3 
MUAC  
< 11.5 cm 
Severe 
visible 
wasting 
Bilateral 
pedal 
oedema 
Oedema only (n= 4) 0 
(0%) 
0 
(0%) 
0 
 (0%) 
0 
 (0%) 
4 
 (100%) 
Wasting only (n= 4) 3 
(75%) 
4 
(100%) 
3 
 (75%) 
4 
 (100%) 
0 
 (0%) 
Marasmus (n= 37) 37  
(100%) 
31  
(84%) 
34 
 (92%) 
34 
 (92%) 
0 
 (0%) 
Kwashiorkor (n= 46) 21 
(46%) 
14  
(30%) 
4 
 (9%) 
3 
 (7%) 
46 
 (100%) 
Marasmic-
kwashiorkor  (n=22) 
22 
(100%) 
16 
 (73%) 
11 
 (50%) 
13 
 (59%) 
22 
 (100%) 
Wasting defined as weight for length Z-score less than -3. 
Kwashiorkor and Marasmic Kwashiorkor defined using Wellcome classification 
MUAC= mid upper arm circumference 
 
Following the reclassification, there were 50 (44%) children with kwashiorkor, 41 (36%) with 
marasmus, and 22 (20%) with marasmic kwashiorkor.   
Marasmic children were more likely to be HIV positive than those with kwashiorkor or marasmic 
kwashiorkor (83% vs. 33%, Odds ratio [OR] 9.7, 95% confidence interval [95% CI] 3.5–29.1, p< 0.001), 
while children with kwashiorkor were less likely to be HIV positive compared to the others (32% vs 
67%, OR 0.24, 95% CI 0.1–0.6, p< 0.001) (Table 3.2).  
Table 3.2 HIV infection rates in different types of malnutrition (N=113). 
 Total HIV positive 
n (%) 
N=58 
HIV negative 
n (%) 
N=55 
Odds ratio 95% CI p value 
Kwashiorkor 50 16 (32) 34 (68) 0.24 0.1 – 0.6 < 0.001 
Marasmus 41 34 (83) 7 (17) 9.7 3.5 – 29.1 < 0.001 
Marasmic 
kwashiorkor 
22 8 (36) 14 (64) 0.47 0.16 – 1.3 0.15 
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Children with kwashiorkor were older than those with marasmus and marasmic kwashiorkor 
(Medians: 15.0 vs. 6.0 and 10.5 months, p< 0.001 and p= 0.04 respectively). HIV positive children 
were younger than HIV negative children, although the difference was not significant (Median age 8 
vs. 12 months, p= 0.15). Fifteen infants (13%) were aged less than three months: two (13%) had 
marasmic kwashiorkor, three (20%) had kwashiorkor and 10 (67%) had marasmus. Eleven (73%) of 
these young infants were HIV positive. This higher prevalence of HIV in severely malnourished 
infants under three months was not statistically significant (OR 2.98, 95% CI 0.8-14, p=0.07). 
Anthropometrics 
One hundred and one (89%) of the children’s lengths and head circumferences were re-
measured by the researcher, following admission. This revealed discrepancies with the 
measurements in the child’s hospital file, especially with regard to length. On average, the lengths 
differed by 2.74 cm (range 0–13 cm) and the head circumference by 0.71 cm (range 0–3 cm). For the 
length, the measurements differed by more than 2.5 cm in 43% of cases. For the majority of these 
(84%), the researcher’s value was higher than that recorded in the file.  
Fifty two children (48%) had a mid-upper arm circumference (MUAC) of less than 11.5 cm. A 
MUAC of less than 11.5 cm was compared to a WHO classification of severe wasting (weight for 
length Z-score < -3). The sensitivity and specificity of a MUAC of < 11.5 cm for severe wasting was 
74% and 75% respectively. This translates to a positive likelihood ratio of 2.91 and a negative 
likelihood ratio of 0.34. 
3.2. History 
Presenting complaint 
The three commonest presenting complaints were coughing (52%), diarrhoea (52%) and fever 
(29%). A history of coughing was more common in the wasted or marasmic group of children than in 
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those with kwashiorkor (OR 3.34, 95% CI 1.3–8.9, p= 0.01). Chronic cough (more than 14 days) 
showed a similar trend, but this was not statistically significant (OR 2.18, 95% CI: 0.6–9.2, p= 0.24). 
Fever was also more common in marasmic children (OR 3.45, 95% CI: 1.3-9.8, p= 0.01) (Table 3.3). 
Table 3.3 Presenting complaints according to type of malnutrition (N=113). 
 Total Kwashiorkor 
n (%) 
N=50 
Marasmus 
n (%) 
N=41 
Odds 
ratio 
 
95% CI p value 
Diarrhoea 47 25 (50) 22 (54) 0.86 0.4–2.1 0.83 
Persistent diarrhoea 7 5 (10) 2 (5) 2.17 0.3–24 0.45 
Cough 50 21 (42) 29 (71) 0.30 0.1–0.8 0.01 
Chronic cough 13 5 (10) 8 (20) 0.46 0.1–1.8 0.24 
Fever 29 10 (20) 19 (46) 0.29 0.1–0.8 0.01 
 
Past medical history 
Almost half the children (46%) had previously been admitted to a hospital. This was more 
common in the HIV positive group (62% vs. 29%, OR 4.0, 95% CI 1.7–9.5, p< 0.001). The caregivers of 
13 (36%) of the HIV positive children who had been previously admitted claimed that this was the 
first time their child was diagnosed with HIV. 
The majority (86%) of children whose immunisation status was known were up to date with their 
immunisations. Only 2 children (2%) had never been immunised, while 11 (12%) were missing one or 
more immunisations.  
Although 17 children (15%) had a close tuberculosis contact when asked about this on history, 
none of them were started on isoniazid prophylaxis prior to admission, as is recommended in the 
national tuberculosis guidelines. Five of these 17 children (29%) were started on TB treatment during 
this admission; all of the others commenced TB prophylaxis. 
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Breastfeeding 
 Information on breastfeeding data was available for 82 children (73%). This data is summarised 
in table 3.4. Only 4% of children were currently breastfed, with more than half (56%) never 
breastfed.  There was a trend towards HIV negative children with a negative mother being more 
likely to have been breastfed (previously or currently) (OR 5.4, 95% CI 0.9-35.0, p=0.06).  
Table 3.4 Child’s breastfeeding status according to child and mother’s HIV infection status 
(N=82) 
 Currently breastfeeding 
n (%) 
Previously breastfed 
n (%) 
Never breastfed 
n (%) 
Child HIV positive, 
mother positive 
2 (4) 17 (37) 27 (59) 
Child HIV negative, 
mother positive 
0 (0) 4 (25) 12 (75) 
Child HIV negative, 
mother negative 
1 (7) 8 (57) 5 (36) 
Child HIV negative, 
mother’s status 
unknown 
0 (0) 4 (67) 2 (33) 
Total 3 (4) 33 (40) 46 (56) 
 
3.3 Clinical features 
Clinical features commonly found in malnourished children are summarised in table 3.5 and 3.6. 
Of note is the frequent finding of dehydration and shock, and of signs associated with HIV disease: 
hepatosplenomegaly, lymphadenopathy and oral candidiasis. Children with HIV were significantly 
more likely to have hepatomegaly (OR 3.3, 95% CI 1.1-11, p=0.03), lymphadenopathy (OR 6.4, 95% CI 
2.4-16, p<0.001), oral candidiasis (OR 2.4, 95% CI 1.0-5.7, p=0.05), respiratory distress (OR 4.1, 95% 
CI 1.5-12, p= 0.002) and splenomegaly (OR 4.5, 95% CI 1.1-26, p=0.02). 
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 Table 3.5 Clinical signs classified by Wellcome classification status (N=113) 
 Total 
n (%) 
N= 113 
Kwashiorkor 
n (%) 
N= 50 
Marasmus 
n (%) 
N= 41 
Marasmic 
kwashiorkor 
n (%) 
N= 22 
p-value 
Hepatomegaly 92 (81) 41 (82) 34 (83) 17 (77) 0.85 
Lymphadenopathy 72 (64) 28 (56) 31 (76) 13 (59) 0.14 
Pallor 61 (54) 25 (50) 22 (54) 14 (64) 0.57 
Dehydration 60 (53) 22 (44) 24 (59) 14 (64) 0.21 
Oral candidiasis 40 (35) 10 (20) 19 (46) 11 (50) 0.01 
Respiratory distress 32 (28) 9 (18) 20 (49) 3 (14) <0.01 
Shock 21 (19) 10 (20) 7 (17) 4 (18) 0.94 
Weeping dermatitis 7 (6) 5 (10) 1 (2) 1 (5) 0.31 
Splenomegaly 15 (13) 3 (6) 9 (22) 3 (14) 0.08 
Conjunctival 
ulceration 
8 (7) 6 (12) 0 (0) 2 (9) 0.08 
Hypothermia (<35 C̊) 6 (5) 3 (6) 3 (7) 0 (0) 0.45 
Bruising or 
petechiae 
3 (3) 3 (6) 0 (0) 0 (0) * 
Jaundice 0 (0) 0 (0) 0 (0) 0 (0) * 
* p value could not be calculated as two or more cells= 0 
 
Table 3.6 Clinical signs classified by HIV status (N=113) 
 Total 
n (%) 
N= 113 
HIV positive 
n (%) 
N= 58 
HIV negative 
n (%) 
N= 55 
Odds 
ratio 
95% CI p 
value 
Hepatomegaly 92 (81) 52 (90) 40 (73) 3.3 1.1 -  11 0.03 
Lymphadenopathy 72 (64) 48 (83) 24 (44) 6.2 2.4 - 16 <0.01 
Pallor 61 (54) 30 (52) 31 (56) 0.8 0.4 – 1.9 0.71 
Dehydration 60 (53) 36 (62) 24 (44) 2.1 0.9 – 4.8 0.06 
Oral candidiasis 40 (35) 26 (45) 14 (25) 2.4 1.0 – 5.7 0.05 
Respiratory distress 32 (28) 24 (41) 8 (14) 4.1 1.5 - 12 <0.01 
Shock 21 (19) 13 (22) 8 (15) 1.7 0.6 – 5.2 0.34 
Splenomegaly 15 (13) 12 (21) 3 (5) 4.5 1.1 - 26 0.02 
Conjunctival ulceration 8 (7) 4 (7) 4 (7) 0.9 0.2 – 5.4 0.90 
Weeping dermatitis 7 (6) 1 (2) 6 (11) 0.1 0.00 – 1.3 0.06 
Hypothermia (<35 C̊) 6 (5) 2 (3) 4 (7) 0.5 0.04 – 3.4 0.43 
Bruising or petechiae 3 (3) 1 (2) 2 (4) 0.5 0.01 – 9.2 0.61 
Jaundice 0 (0) 0 (0) 0 (0) * * * 
* OR, 95% CI and p value not calculated as both cells= 0 
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3.4 Laboratory results 
Although the mean haemoglobin was low (8.9 g/dl) on admission, only one child had an absolute 
indication for blood transfusion according to the WHO guidelines (haemoglobin of ≤ 4 g/dl). An 
additional 10 children may have qualified if they showed signs of cardiac decompensation as a result 
of the anaemia (haemoglobin of 4 to 6 g/dl). Twenty five (22%) children received one or more blood 
transfusions, but not all of these were given on the basis of the admission haemoglobin result: some 
were transfused on the basis of a later result, which was not captured by the researcher. Eight 
children (7%) had a platelet count of less than 100,000/µl. 
Hypokalaemia (potassium < 3.0 mmol/l) occurred in 32% of patients, while the bicarbonate 
value was less than 17 mmol/l in 52%. Elevated C-reactive protein levels (>10 mg/l) were seen in two 
thirds of children (67%), with 47 (44%) having a level over 40 mg/l. Albumin levels were checked on 
all 72 children with oedematous malnutrition, and 22 of 41 (54%) of the marasmic children. 
Although there was a significantly lower albumin in the group with oedema (23.2 versus 29.4 g/l, p< 
0.001), there was a significant overlap between the two groups. The range of albumin levels in the 
oedematous group was 9 to 38 g/l, while in the marasmic groups values ranged between 19 and 40 
g/l.  Eleven (10%) of patients had an INR of greater than 1.7 (table 3.7). 
Table 3.7 Laboratory investigations classified by Wellcome classification status (N=113) 
 Total 
n/N (%) 
Kwashiorkor 
n/N (%) 
 
Marasmus 
n/N (%) 
 
Marasmic 
kwashiorkor 
n/N (%) 
Haemoglobin < 6 g/dl 11/113 (10) 4/50 (8) 5/41 (12) 2/22 (9) 
Platelets < 100,000/µl 8/113 (7) 3/50 (6) 3/41 (7) 2/22 (9) 
Potassium < 3,0 mmol/l 36/113 (32) 18 /50(36) 9/41 (22) 9/22 (41) 
Bicarbonate < 17 mmol/l 59/112 (53) 22 /49(45) 23/41 (56) 14/22 (64) 
CRP > 10 mg/l 72/108 (67) 35/49 (71) 27/40 (68) 10/19 (53) 
Albumin < 30 g/dl 72/98 (73) 43/50 (86) 13/26 (50) 16/22 (73) 
INR > 1.7 11/58 (19) 6/39 (15) 2/2 (100) 5/17 (29) 
CD4 cell count < 20% 30/59 (51) 11/16 (69) 13/34 (38) 6/9 (67) 
* N varies because not all patients had each investigation. 
22 
 
3.5. Infections 
Urinary tract infection  
Thirty seven children (33%) had laboratory evidence of a urinary tract infection, based on the 
criteria explained in section 2.7.4. Nine (24%) of these failed to culture an organism or cultured 
contaminating organisms, but 76% of the samples cultured a likely organism. These included 
Escherichia coli (24), Klebsiella pneumoniae (3) and Proteus mirabilis (1). 
Septicaemia  
 A high incidence of bacteraemia (23%) also prevailed. Of all patients, 26 (23%) had at least one 
positive blood culture that was unlikely to be a skin contaminant (pseudo-bacteraemia). Organisms 
cultured are listed in table 3.8. Escherichia coli was the most commonly isolated organism. All four 
children that grew Haemophilus influenzae in their blood culture were fully immunised according to 
their Road to Health cards, and three of the four (75%) were HIV positive. The incidence of 
septicaemia did not differ significantly between children with marasmus, kwashiorkor or marasmic 
kwashiorkor (29%, 18% and 23% respectively). Similarly, HIV positive children had more positive 
blood cultures than HIV negative children (26% vs 20%), but once again this difference was non-
significant. 
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Table 3.8 Organisms cultured from blood in children with severe acute malnutrition (N=113). 
Organism No. Relative 
contribution (%) 
Escherichia coli 7 27 
Haemophilus influenzae 4 15 
Streptococcus pneumoniae 4 15 
Staphylococcus aureus 3 12 
Klebsiella pneumoniae* 2 8 
Streptococcus agalactiae 2 8 
Salmonella species 1 4 
Enterococcus cloacae 1 4 
Fungi (Candida species) 2 8 
Total 26 100 
* Both of these were extended spectrum beta-lactamase producing bacteria. 
Tuberculosis 
Pulmonary tuberculosis was a frequently suspected but seldom proven infection in 
malnourished children. Of 32 tuberculin skin tests whose result was recorded, only one was positive 
(PPD > 10mm). Gastric washings or induced sputa were done on 64 children, and yielded one 
positive microscopy for acid fast bacilli, and two positive Tuberculosis mycobacterium cultures. None 
of the six blood cultures for tuberculosis yielded any positive results. One child was suspected of 
having tuberculosis meningitis based on CT scan and lumbar puncture findings. This adds up to five 
children with “laboratory” evidence for tuberculosis, yet a total of 27 children were strongly 
suspected of having the disease on history, examination and chest X-rays, and were subsequently 
started on tuberculosis treatment. Marasmic and HIV positive children had TB treatment started 
more frequently, but the group with the highest rate of suspected tuberculosis was the HIV negative 
marasmic children: four of seven (57%) were started on treatment (table 3.9). 
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Table 3.9 TB treatment according to malnutrition type and HIV status (N= 113)  
 Number treated (%) p value 
WELLCOME CLASSIFICATION   
Kwashiorkor (n= 50) 8 (16)  
Marasmus (n= 41) 16 (39)  
Marasmic kwashiorkor (n= 22) 3 (14) 0.02 
HIV STATUS   
HIV positive (n= 58) 17 (29)  
HIV negative (n= 55) 10 (18) 0.19 
Other infections 
Other identified infections included one parvovirus B19 infection and one cytomegalovirus 
infection (both diagnosed using DNA polymerase chain reaction). 
 
3.6. Patient management 
All children were started on intravenous antibiotic therapy, 27 (24%) on anti-tuberculosis 
treatment, and 19 (17%) on anti-fungal treatment. All except two of the children started on 
antifungal treatment were started based on a clinical suspicion of oesophageal candidiasis. The two 
exceptions occurred in children where Candida species were cultured in their blood specimens. 
Twenty five (22%) of children had one or more blood transfusions, while six (5%) received 
intravenous infusions of fresh frozen plasma.  
Sixteen children (28% of HIV positive children) were on highly active antiretroviral therapy 
(HAART) in hospital, with 12 (75%) of them having been on the drugs prior to the current admission.  
Treatment of malnutrition included the administration of vitamins and minerals, and the 
administration coverage rates are shown in table 3.10. The WHO guidelines recommending 
administration of measles vaccine to all children over six months of age who have not received it 
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previously, was poorly followed: of 25 children who qualified for this vaccine, only eight (32%) 
received it. Treatment with zinc, vitamin A and folate were particularly poor in marasmics compared 
to kwashiorkor (OR 0.06, 95% CI 0.01-0.28, p< 0.001; OR 0.02, 95% CI 0.00-0.14, p< 0.001 and OR 
0.09, 95% CI 0.03-0.30, p< 0.001 respectively). 
Table 3.10 Administration of vitamins and minerals in children with severe acute malnutrition 
(N=113). 
 Total 
n (%) 
N= 113 
Kwashiorkor 
n (%) 
N= 50 
Marasmus 
n (%) 
N= 41 
Marasmic-
kwashiorkor n (%) 
N= 22 
Potassium 75 (66) 46 (92) 12 (29) 17 (77) 
Zinc 87 (77) 47 (94) 20 (49) 20 (91) 
Vitamin A 71 (63) 47 (94) 9 (22) 15 (68) 
Vitamin K 62 (55) 46 (92) 1 (2) 15 (68) 
Multivitamins 69 (61) 32 (64) 24 (59) 13 (59) 
Folate 78 (69) 44 (88) 16 (39) 18 (82) 
3.7. Outcomes 
Final outcome 
Thirteen children (12%) died in hospital, 81 children (72%) were discharged directly from 
hospital, while 19 (17%) were transferred to Selby Park Hospital (a recuperation down-referral 
centre). All children transferred to Selby Park Hospital survived and were later discharged.  
Mortality 
Six deaths (46%) occurred within 48 hours of admission. Six of the nine (67%) HIV positive 
children who died were diagnosed for the first time during this admission. 
Marasmus had a worse mortality than kwashiorkor, though this was not statistically significant 
(14% vs. 8%, OR 1.97, 95% CI 0.43–10.2, p= 0.34). The marasmic kwashiorkor group was closer to the 
marasmic group in terms of outcome (case fatality rate: 13.6%). HIV was a significant poor 
prognostic factor: 19% of positive children died compared to 3.6% of HIV negatives (OR 6.2, 95% CI 
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1.24–59, p= 0.016) (table 3.11). Survival analysis confirmed a statistical difference between HIV 
positive and negative children (p= 0.018) (figure 3.3). 
Table 3.11 Mortality of severe malnutrition according to type of malnutrition and HIV status (N=113) 
 
  Case fatality rate (%) p value 
WELLCOME CLASSIFICATION 
Kwashiorkor 4/50 (8)  
Marasmus 6/41 (15)  
Marasmic kwashiorkor 3/22 (14) 0.58 
HIV STATUS   
HIV positive 11/58 (19)  
HIV negative 2/55 (3.6) 0.02 
 
Figure 3.3 Survival of hospitalised severely malnourished children during the first four weeks 
after admission according to HIV status. 
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Duration of stay 
The duration of stay averaged 12.7 days for the group of children who were discharged directly 
from their admitting hospital (Range 3 to 40 days, median 11 days). The total time spent in hospital 
by the Selby Park group of children (including the time spent at the admitting hospital) was 18.7 days 
on average (range 8 to 60 days, median 14 days). The total duration of stay of surviving patients did 
not differ between HIV positives and negatives (13.9 and 13.7 days respectively).  For the 13 deaths, 
time from admission to death was a median of 3 days (IQR 1-6, range 1 to 30 days).  
3.8. Poor prognostic factors 
Several factors were tested against the likelihood of dying using univariate analysis. The factors 
that were considered for inclusion were chosen on evidence from previous publications on this 
subject (see section 1.6). Because of the low number of fatalities in the study, risk factors were 
tested for both all children and specifically for those with oedematous malnutrition (kwashiorkor 
and marasmic kwashiorkor).  
Bruising or petechiae occurred in 13 patients, but none died. Jaundice did not occur in any 
patients, but it is probably a poor prognostic factor in view of the degree of liver dysfunction 
required to produce this sign. Some factors that indicate more severe disease were statistically 
significant: hypoglycaemia, a prolonged clotting time and corneal ulcerations are examples. 
Surprisingly, a low CD4 cell count (< 20%) was not a poor prognostic factor in this sample. 
Conversely, pallor, shock, and blood transfusions were significant risk factors. Further results are 
shown in table 3.12. 
3.9. Causes of death 
Septicaemia and septic shock were thought to be responsible for nine deaths (69%). Six children 
(67%) had positive blood cultures to support this finding. The responsible organisms were Eschericia 
coli, Enterobacter cloacae, extended beta-lactamase producing Klebsiella pneumoniae, 
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Staphylococcus aureus, and Streptococcus pneumoniae. Other suspected causes of death included 
pneumonia, cardiac failure secondary to fluid overload and immune reconstitution inflammatory 
syndrome in an HIV positive patient recently started on antiretrovirals. 
Table 3.12 Poor prognostic factors for all severe malnutrition (N=113) and kwashiorkor deaths 
(N=72)  
 All patients 
 (deaths= 13) 
Oedematous malnutrition  
(deaths= 7) 
Odds 
ratio 
95% CI p value Odds 
Ratio 
95% CI p value 
CLINICAL FINDINGS 
Hypothermia 9.7 1.6 – 59 < 0.01 15.5 1.9 – 125 < 0.01 
Shock 7.2 1.9 – 26 < 0.01 42.7 2.9 – 638 < 0.01 
Corneal ulcers 5.7 1.1 – 28.8 0.02 9 1.4 – 58.5 0.01 
Pallor 5.5 1.1 - 27.3 0.02 6.47* * 0.01 
LABORATORY FEATURES 
INR > 1.7 9.8 2.2 – 43.4 < 0.01 24.6 2.8 – 213.2 < 0.01 
Glucose <2.5mmol/l 9.7 1.6 – 59.3 < 0.01 15.5 1.9 – 125.3 < 0.01 
Haemoglobin < 6 g/dl 5.9 1.4 – 25.5 0.01 6.1 0.8 – 45.0 0.24 
Platelets <100 (x103/µl) 5.7 1.1 -28.8 0.02 23.6 2.3 – 244.1 < 0.01 
Bacteraemia 3.4 1.0 – 11.7 0.05 7.3 1.3 – 41.8 0.01 
Urinary tract infection 2.7 0.8 – 9.0 0.08 2.4 0.5 – 12.1 0.26 
Bicarbonate < 17mmol/l 2.3 0.6 – 7.9 0.19 2.7 0.5 – 15.6 0.24 
CRP > 10mg/l 2.0 0.5 – 8.0 0.31 4.0 0.4 – 36.7 0.19 
Potassium < 3 mmol/l 1.8 0.5 – 6.4 0.37 1.3 0.2 – 7.7 0.75 
INTERVENTIONS 
Fresh frozen plasma 9.7 1.6 – 59.3 < 0.01 23.6 2.3 – 244 < 0.01 
Blood transfusion 7.8 2.1 – 29.2 < 0.01 42.8 2.9 – 638 < 0.01 
Antiretroviral treatment 3.3 0.6 – 14.0 0.09 12.6 0.7 - 194 0.05 
TB treatment 0.2 0.01 – 1.8 0.18 0 0 – 4.0 0.59 
* OR and 95% CI could not be estimated as one cell value was zero.  
Statistically significant odds ratios have been highlighted in bold. 
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3.10. HIV Status 
Of all HIV positive children in this study, 31 (54%) had never been diagnosed with HIV prior to 
this admission according to their caregivers. Only two of these children were younger than two 
months. The other 29 could have been diagnosed through routine testing of six week old HIV 
exposed infants if this were available (it is national policy to offer this). 
Forty seven children had CD4 cell counts done (81%): the mean CD4% was 22%, SD 10.8. A CD4% 
of less than 20% was not a poor prognostic factor: 13% of those with a CD4% less than 20% died, 
versus 24% of those with a CD4% greater than 20% (OR 0.5, 95% CI 0.09–2.23, p= 0.3)  
Twenty six HIV positive children (46%) were known to be seropositive before the current 
admission. Twelve of these children (46%) were on highly active antiretroviral therapy prior to 
hospital admission. The majority of these children (83%) were on treatment for less than two 
months (Figure 3.4). Of four children who were started on treatment during this admission, two 
(50%) subsequently demised. Two of the twelve (17%) children who were on HAART prior to this 
admission died; both of them had been on treatment for less than two months. 
 
Figure 3.4 Duration of antiretroviral therapy in HIV infected children prior to admission (N= 12). 
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3.11. The HIV “affected” children 
Among the HIV negative children whose mother’s HIV status was known, just over half (19/37 
[51%]) were “HIV exposed” during the intrapartum, antenatal and postpartum period. In the general 
population, this ratio would be expected to be significantly lower: assuming an HIV prevalence of 
30% in antenatal clinics in Gauteng and a vertical transmission rate of 10%, the general population 
would have 3% of all children infected, 27% exposed but negative and 70% negative and not 
exposed. HIV affected children were thus more likely to become severely malnourished than their 
non HIV exposed counterparts. No difference was found in the mortality between exposed and non-
exposed HIV negative children (6% and 5% respectively). None of the 18 HIV negative children whose 
mother’s status was unknown died. The total duration of hospital stay also did not differ significantly 
(13.8 days vs 11.2 days, p= 0.16) (table 3.13). 
Table 3.13 Differences between HIV positive, HIV exposed but negative (“HIV affected”) and HIV 
non-exposed children (N= 95, [18 mothers’ status was unknown]) 
 HIV positive 
N=58 
n(%) 
HIV Affected 
N= 19  
n(%) 
Not HIV exposed 
N=18  
n(%) 
Kwashiorkor 16 (28) 8 (42) 10 (56) 
Marasmus 34 (59) 4 (21) 3 (17) 
Bacteraemia 15 (26) 3 (16) 5 (28) 
Suspected TB 17 (29) 4 (21) 4 (22) 
Haemoglobin < 6 g/dl 7 (12) 1 (5) 0 (0) 
Platelets < 100,000/µl 8 (14) 0 (0) 0 (0) 
Case fatality rate 11 (19) 1 (5) 1 (6) 
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4. Discussion 
4.1. Main findings: 
This study confirms that a case fatality rate of less than five percent is difficult to attain in areas 
with a high HIV prevalence, even in well resourced settings. The only group in which this target was 
achieved was in HIV negative children (case fatality rate 3.6%); supporting the notion that HIV 
infection is largely to blame for the excess mortality. Contrary to what Schofield and Ashworth 
described in their literature review on case fatality rates in 1996,(25) marasmus now appears to carry 
a similar, if not worse, early prognosis than kwashiorkor. This effect may be explained by the higher 
prevalence of HIV infection in the marasmic group.  
The median age of the study sample (10 months) was exceptionally young. This finding highlights 
the need for improved infant feeding strategies for HIV exposed infants, especially as 81% of the 
children whose mother’s status was known were HIV exposed. 
Another important finding is the contribution of HIV infection to severe malnutrition in this 
setting, with about half of the enrolled children being HIV positive. This sample confirmed 
differences between the HIV positive and negative children and the malnutrition they suffer. Similar 
to previous studies,(48) HIV positive children were more likely to have marasmus, while the negative 
group predominantly had kwashiorkor. Additionally, HIV positive children were more likely to have 
had previous hospital admissions; they had more hepatomegaly, splenomegaly, lymphadenopathy 
and respiratory distress. 
The search for poor prognostic features revealed some interesting findings, despite being 
somewhat limited by the small number of deaths observed. Besides HIV, the presence of shock (and 
therefore probably intravenous fluid boluses), blood transfusions and evidence of disseminated 
intravascular coagulation (abnormal INR and thrombocytopaenia) were the most notable poor 
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prognostic factors. Additionally, some traditional risk factors (such as corneal ulcers, hypoglycaemia 
and hypothermia) retained prognostic significance.  
As expected, bacterial infections were common and remain an important part of the disease in 
the HIV era. Gastroenteritis, septicaemia and urinary tract infections were common findings. 
Suspected tuberculosis was also prevalent in this sample, while laboratory evidence for the disease 
was typically scarce. It is therefore tragic that the isoniazid prophylaxis programme for young 
children exposed to TB contacts does not appear to be functioning well in Gauteng, with none of the 
children who were exposed to the disease at home being investigated or started on prophylaxis.  
Deaths occurred early in the course of the disease. There was a high prevalence of septicaemia 
and suspected septicaemia in the group of children who died. Similarly, intravenous infusions of 
crystalloid fluids and blood were common, and more prudent use of these may be an area to 
investigate further to try and reduce mortality rates. However, the need for this intravenous therapy 
may also be a reflection of the seriousness of the illness in this group. Lastly, improving the 
Prevention of Mother to Child Transmission of HIV programme (PMTCT), and early diagnosis and 
treatment of HIV in infants, could greatly improve prevention and outcome of severe childhood 
malnutrition. 
4.2. General characteristics 
4.2.1. Anthropometrics 
The discrepancy observed in measurement of length between the researcher and the admitting 
staff was alarming. A discrepancy of greater than 2.5 cm has a significant implication when 
translated into z-scores in children. As this was the case in 43% of patients, the prevalence of 
wasting and stunting may differ significantly according to how the child is measured. The difficulty in 
obtaining an accurate length in a busy admission ward is understandable, particularly when 
measuring boards may be unavailable and some of the children are critically ill. An accurate length is 
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critical however if weight for length z-scores of less than -3 are to be used as the definition for 
severe malnutrition. This has an important bearing in classifying the child at the outset and in 
measuring successful rehabilitation. WHO has clear guidelines how to remediate these common 
problems.(49)  
These obstacles in measuring the length of ill children support the recommendation for more 
widespread use of mid-upper arm circumference (MUAC) measurements.(50) It is easier to carry out 
and is less likely to be susceptible to inter-observer difference. In addition, no accurate scale is 
required, and the measurement requires no interpretation on growth charts. The MUAC 
measurement has been validated in several trials and has been shown to be a good predictor of 
mortality in severely malnourished children, performing at least as well as a weight for length z-
score of less than -3.(50, 51) These publications also describe that using a MUAC < 11.5 cm or a weight 
for length z-score less than -3 identifies different populations with some overlap, but MUAC is less 
likely to be influenced by factors such as acute dehydration or salt and fluid retention as seen in 
kwashiorkor. It may thus be advisable to use the MUAC < 11.5 cm in clinics and primary health care 
settings for diagnosing severe malnutrition, while using both measurements (MUAC and length) is 
advisable in hospital situations, providing staff has been trained in the performance of the correct 
measuring of weights, lengths and heights. 
4.2.2. Patient’s medical history 
A sizeable proportion of children had been previously admitted to a hospital (29% of HIV 
negative and 62% of HIV positive children). Although no further information could be captured with 
regards to the number, reasons and timing of previous admissions and their nutritional status at the 
time of that admission, this finding highlights how the healthcare system is failing to address the 
nutritional needs of children with earlier forms of malnutrition. This was particularly the case in HIV 
positive children, where effective care had not been instituted regardless of whether or not a 
diagnosis of HIV had been made.  
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The immunisation coverage in the sample was reasonably high, especially considering the 
possibly difficult social circumstances the children came from. This implies a reasonable interaction 
with the healthcare services, and again highlights the failure of the system to identify and treat these 
children before they present with severe malnutrition. This failure is essentially a failure of growth 
monitoring and promotion (part of the Integrated Management of Childhood Illnesses programme in 
South Africa), which has been described in other settings.(52) Unless it is linked to adequate nutrition 
counselling and support, and an appropriate referral system, growth monitoring has not been shown 
to reduce malnutrition.(53) 
In addition, the high prevalence of malnutrition is a failure of the health system to prevent the 
earlier forms of the disease in the first place. More emphasis needs to be placed on infant feeding 
strategies, particularly in the HIV setting.  
4.3. Clinical presentation and laboratory features 
4.3.1. Dehydration and shock 
Dehydration was a very common finding (53%) despite being clinically difficult to detect in 
malnourished children. Similarly, a clinical diagnosis of shock was common (19%). Unfortunately, it 
was not possible to differentiate the type of shock; and it is thus not possible to estimate what 
percentage was the result of hypovolaemic, septic, or cardiogenic shock. This may have 
management implications, as excessive fluid resuscitation may have detrimental effects if the 
patient has poor myocardial contractility contributing to his/her shock, as may be the case in 
severely malnourished children.(54) 
4.3.2. Stigmata of HIV infection 
Typical but non-specific features seen in HIV infected children were frequently encountered in 
the HIV negative severely malnourished. Hepatomegaly, lymphadenopathy and oral candidiasis were 
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therefore not useful in predicting an HIV positive status. Splenomegaly was a finding that was more 
specific to HIV infection, but it occurred infrequently. As a conclusion, it is very difficult to predict the 
HIV status of a severely malnourished child from clinical findings. This has been described in previous 
studies.(55) With the high prevalence of HIV in severely malnourished children, this also makes the 
case for routinely testing all severely malnourished children for HIV in this setting.  
4.3.3. Laboratory features 
Serum markers suggestive of sepsis were positive in a large proportion of patients (e.g. CRP was 
raised in two thirds of patients). This, together with the culture-confirmed infections, confirms the 
high incidence of bacterial infection in severely malnourished children. This did not appear to differ 
between HIV infected and non-infected children, nor was it specific to the type of malnutrition. It is 
therefore imperative to continue the use of broad spectrum antibiotics in all children with severe 
malnutrition, despite the absence of strong evidence from a randomised controlled trial, for 
example, supporting this. 
Although the mean albumin level of kwashiorkor patients was lower than the marasmic group, a 
significant overlap was observed (respective ranges: 9 to 38 and 19 to 40 g/dl). This supports the 
notion that oedema in malnutrition is not solely caused by hypoalbuminaemia.(56) 
4.4. Infections 
4.4.1. Bacterial infections 
Bacteraemia and bacterial urinary tract infections were common in all types of severe 
malnutrition. The organisms implicated are similar to those described previously, with a high 
proportion of gram negative bacteria.(40, 44) The first line antibiotics (ampicillin and gentamicin) used 
in this setting remain appropriate choices. 
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4.4.2. Tuberculosis 
The prevalence of suspected TB was high (27%). The incidence of TB cases has been rising rapidly 
in Gauteng,(57) and this appears to be reflected in this sample. Evidence other than suspicious X-ray 
findings was not found in 80% of these cases, and the validity of the diagnoses is questionable since 
pulmonary TB remains difficult to diagnose in children.(37) There is limited literature on the 
prevalence of pulmonary TB in severely malnourished children. Amadi and others reported a 
prevalence of 18% in a study in Zambia in 2001.(58)  
It is imperative to get a better handle on the TB prevention programme, especially in children. 
Contact tracing and isoniazid prophylaxis to children under five years is a proven and effective 
strategy (59) and it appears it is not being practiced adequately in Gauteng. This needs to be 
addressed at a programmatic level, but physicians who are diagnosing adult or paediatric TB also 
need to be reminded to look for both a source of the infection and identify other contacts that 
require screening and/or prophylaxis. 
4.5. Patient management 
As mentioned in section 2.8, the management of severely malnourished children in this setting 
differed in several ways from the WHO recommendations, which are discussed below.  
4.5.1. Feeding 
Instead of the recommended F-75 and F-100 formulas suggested by the WHO,(3) the children are 
assessed individually by dieticians and humanised milk is prescribed. Aside from the lower levels of 
micronutrients in this milk, which are dealt with in the following paragraph, there are differences in 
the macronutrient contents of these milks. While there is a lower content of protein (0.9 vs. 1.8 to 3 
g/100ml) and fat (2 vs. 4.4 to 6 g/100ml) in F-75, the carbohydrate content is higher 13.3 vs. 9 to 14 
g/100ml).(3, 60) Most importantly, F-75 has a higher the caloric content than humanised milk (75 vs. 
60 to 70 kcal/100ml), and this is even more important in the rehabilitation phase, when F-100 with 
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100kcal/100ml is used. However, during this next stage, local children are usually supplemented  
with additional foods. 
Unfortunately, ready to use therapeutic foods which have been so successfully used in 
nutritional rehabilitation of malnourished children in other parts of Africa,(61) are not available to our 
local children. 
4.5.2. Micronutrients 
The micronutrient mix recommended in the WHO “ten steps” guidelines is not generally 
available at South African hospitals outside of a study setting.(28, 62) With the exception of potassium, 
these micronutrient deficiencies are not thought to contribute to in-hospital fatalities, and many 
recommended micronutrients were available in other forms in the hospitals included in this study. 
The only micronutrient deficiencies not specifically addressed were copper, selenium, iodine and 
magnesium. Supplementation with magnesium could be achieved by using a 50% magnesium 
sulphate mixture given orally or intramuscularly.(3) Despite the availability of the other required 
micronutrients, a large percentage of children did not receive some of the supplements, particularly 
multivitamins (in all groups), and zinc, vitamin A and folate in marasmic children. Even if this may not 
negatively affect case fatality rates, it is an issue that needs to be addressed at each hospital. 
4.5.3. Measles vaccination 
Measles vaccination was another frequently missed intervention. The WHO “ten steps” 
recommend immunising all children over six months old who do not have evidence of prior 
immunisation. In a setting where hospital wards are frequently crowded, these children who are 
immune compromised because of their malnutrition are thus placed at a significant risk. The recent 
outbreak of measles in the province and nationally is a reminder that measles remains a pervasive 
risk. Again, this deficiency needs to be specifically addressed at each hospital. 
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4.5.4. Highly active antiretroviral treatment (HAART) 
All the children enrolled in this study qualified for HAART according to the South African national 
antiretroviral guidelines because severe malnutrition results in HIV positive children being classified 
as having WHO stage IV disease.(63) Only 12 children were on HAART prior to study admission, and 
two (17%) of the children died during their hospital stay (both were within the first two months of 
starting HAART). Of the four patients who were started on HAART during this admission, two died 
(50%). Although this may seem a very high mortality rate, a high mortality within 90 days of starting 
HAART has been previously described in Sub-Saharan African settings. This high mortality may be 
due to a combination of starting treatment too late in the course of HIV disease and the possible 
development of an immune reconstitution inflammatory syndrome (IRIS).(64)  
The development of kwashiorkor has also been described as being a result of IRIS,(65) with 
possible reconstitution of the immune system activating the pathophysiological pathway that leads 
to the clinical features of kwashiorkor. This newly observed phenomenon may add further insight 
into the pathogenesis of kwashiorkor, even in HIV negative children. 
The initiation of HAART in severely malnourished children is not a well researched field. It is 
unclear whether it is better to start HAART before, during or after nutritional rehabilitation and 
there is not enough data on the pharmacokinetics of antiretroviral drugs in malnourished 
children.(66) Further complicating the decision of best timing is the need to manage concurrent TB in 
many children. TB treatment in HIV positive children who also need HAART is tricky: both TB IRIS and 
possible drug interactions and toxicities need careful consideration and monitoring. In the era of 
HIV, the management of HIV-infected severely malnourished children needs to be better researched 
and incorporated into revised international guidelines. 
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4.5.5. Blood transfusions 
Twenty five children (22%) received a blood transfusion during their hospital stay. Indications for 
blood transfusion according to the WHO “10 steps” guidelines are to transfuse all children with 
haemoglobin below 4 g/dl, and those with haemoglobins of 4 to 6 g/dl and signs of cardiac failure.(3) 
In this study only one child had a haemoglobin level below 4 g/dl, and 10 had a haemoglobin 
between 4 and 6 g/dl. However, these were only values captured on admission, and they do not 
necessarily reflect the pre-transfusion haemoglobin level. The indication and date of transfusions 
were also not captured. 
The recommended packed cell transfusion volume is 4 ml/kg body weight over three hours.(3) At 
the study sites, the usual volumes that were transfused were 20 ml/kg, albeit somewhat slower, 
over four to six hours. Although volumes transfused, rate of transfusion and adverse outcomes of 
the transfusions were not captured, it must be noted that in previous studies blood transfusions 
carried poor prognostic implications for children with severe malnutrition.(32) It has not been 
determined whether this is linked to the actual blood transfusion or whether the need for a 
transfusion is an indicator of more severe disease. Further research is needed to investigate the 
ideal indication, volumes and rates of blood transfusions in severely malnourished children. 
4.6. Outcomes  
The main outcome of this study was the in-hospital case fatality rate of severe childhood 
malnutrition in a high HIV prevalence setting. Whereas this has been investigated elsewhere in 
impoverished settings,(27-29) an extensive literature review did not reveal any such studies in a 
resource privileged, urban academic setting. It is therefore an important finding that even in such a 
setting the overall case fatality remained well over 5%.  
Consideration must be given to admission criteria - was this sample of children less or more sick 
than severely malnourished children elsewhere? The attending doctors decided whether to admit a 
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child or whether to follow him or her up as an outpatient. In practice, all children with oedematous 
malnutrition are usually admitted; but a considerable amount of marasmic patients may be treated 
at home. In contrast, the management of uncomplicated severely malnourished children (including 
kwashiorkor) elsewhere in Africa has recently been shown to be as effective when done in an 
outpatient setting and using ready to use food.(61, 67) This study sample may thus include less ill 
children compared to settings where ready to use food is available, where only “complicated” 
malnutrition demands admission.  
Regardless of admission criteria, it remains clear that mortality rates less than 5% remain 
unachievable, except in HIV negative children. Clearly, HIV infection is a large contributing factor to 
the excess mortality seen in these children, with an odds ratio of 6.2 (95% CI 1.24–59). This once 
again highlights the need to research the management of this disease in HIV positive children, and to 
revise the WHO “10 steps” guidelines to incorporate this new research. 
4.7. Prognostic factors and direct causes of death 
Poor prognostic factors described in the pre-HIV era were mainly features of severe 
kwashiorkor, and features that could directly cause death. Severe kwashiorkor is characterised by 
liver dysfunction, and hence hepatomegaly, jaundice and bruising were frequently quoted as factors 
predictive of death. Features that may directly cause death unless treated include hypoglycaemia, 
hypothermia and hypokalaemia. Others, such as weeping dermatitis, are features of severe disease 
and may be involved in causing septicaemia. These direct causes of death were addressed in the 
WHO “10 steps” management guidelines, and its implementation could thus reduce fatality rates. 
Now that most deaths occur in marasmic and HIV positive patients, the contribution of other factors 
warrants study.  
In this study, the search for these factors was limited by the small number of deaths observed. 
Nevertheless, some factors that may indicate more severe disease were once again predictive of a 
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fatal outcome: hypoglycaemia and corneal ulcers are examples. Several factors that may be related 
to septicaemia were also strongly predictive: bacteraemia, prolonged prothrombin index, 
thrombocytopaenia and the administration of fresh frozen plasma are examples. The latter is 
frequently given for intractable shock and prolonged bleeding in patients with a prolonged INR. 
Pallor, shock and blood transfusions were factors that deserve a special mention. Perhaps the 
pallor and the shock were markers for patients that received higher volumes of intravenous fluids or 
blood transfusions. It is possible that the higher volume of intravenous fluids administered to 
children with shock predisposed these children with poorly contractile hearts to cardiac failure.(54) 
This is difficult to prove as the amount, date and time of infusions were not captured to compare to 
the time of death. Infusing large amounts of fluids and overhydration has been recognised as a cause 
of death in malnourished children.(25) However, these three factors are perhaps also markers of more 
severe disease, and an observational study such as this cannot differentiate whether the initial 
severe disease or the intervention was to blame for the patient’s fatal outcome. 
An attempt was made to assign an immediate (direct) cause of death to each child that died. 
Septicaemia and septic shock were the most common causes identified. This was despite the 
administration of intravenous antibiotics to all these children from the time of admission. To prevent 
similar deaths in future, the primary health care management of earlier forms of the disease and 
prevention of severe malnutrition must be addressed.  
Several poor prognostic factors were similar to what was found in recent research by Maitland 
and colleagues in Kenya.(31) Hypothermia, hypoglycaemia and shock were significant common factors 
in both studies, and should guide the clinicians in these settings to identify patients at highest risk of 
death. 
 
42 
 
4.8. HIV infected children 
The high prevalence of HIV in this sample and the high case fatality rate of HIV positive children 
identify an area where a large impact can be made on reducing child deaths from severe 
malnutrition. It is tragic to see that over half of the positive children in this sample, and two thirds of 
the positive children who died, were diagnosed with HIV for the first time during this admission. This 
is unacceptable in a province where there is widespread availability of prevention of mother to child 
transmission of HIV (PMTCT) and infant diagnosis programmes. It is possible that a proportion of 
patients were in fact not from Gauteng province. Place of residence was difficult to ascertain and 
was not captured for the purpose of this study. Another possibility is that some mothers may not be 
disclosing their prior knowledge that the child was HIV positive. 
It is imperative that PMTCT and infant diagnosis services are strengthened in all areas to 
facilitate prevention of vertical transmission and early diagnosis where this prevention fails. The 
CHER study provides clear evidence that treating all HIV positive infants with HAART dramatically 
increases their chance of survival.(24) By combining improved PMTCT and early HAART for HIV 
positive infants strategies, government policies could have a dramatic impact on the burden of HIV 
on children and child mortality. A recent study by Hughes and colleagues supports this 
recommendation further: CD4 counts of severely malnourished HIV positive children continued to 
decline despite nutritional rehabilitation. By the time the children reached full nutritional recovery, 
over 85% required HAART because of low CD4 counts.(68) 
A discussion of HIV and childhood malnutrition would not be complete without discussing the 
controversial topic of the feeding of HIV exposed infants. Healthcare workers and HIV positive 
mothers need to weigh up the risks of breastfeeding and possible transmission of the virus versus 
formula feeding, with the risk of malnutrition, diarrhoea and other infections, and possibly death.(69) 
This difficult decision is frequently complicated by biased healthcare workers, the option of receiving 
free formula, and the stigma associated with formula feeding in certain settings. In addition, the 
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issue is further complicated by the difficulty of maintaining exclusive breastfeeding in mothers who 
are potentially ill themselves, and by the conflicting advice on how to wean children off breast 
milk.(69) However; there may be light on the horizon. Evidence is accumulating that breastfeeding 
may be safe if the mother or infant is on antiretroviral therapy during this period,(70, 71) and it is now 
recommended in the new WHO infant feeding guidelines. (72) 
Breastfeeding is protective against developing severe malnutrition.(22) Clearly the low rates of 
breastfeeding observed in this study may have contributed to the development of severe 
malnutrition.  
4.9. HIV affected children 
HIV affected (HIV exposed but negative) children are at a higher risk for malnutrition, infections, 
and dying.(73) This may be due to a combination of factors: less breastfeeding to avoid HIV 
transmission, parental illness or death and increased exposure to infections such as TB. This 
increased vulnerability seems to be borne out in this study: over half of the HIV negative children 
whose mother’s status was known, were in fact HIV exposed. It may therefore be prudent to follow 
these children more closely than is currently the norm. More frequent visits to primary health care 
clinics with frequent growth monitoring and early nutritional interventions may be beneficial. 
Research must also be directed at the potential role of chemoprophylaxis in these children: perhaps 
cotrimoxazole or isoniazid prophylaxis may be warranted during infancy until they are out of the 
danger period. 
No previous literature has reported the outcome of this group of children with severe acute 
malnutrition. It was encouraging to see that the HIV affected children in the study sample behaved 
more like the non-exposed children than the positive children. Although the numbers in these 
groups were too small to make statistically significant observations, case fatality rates and the types 
of malnutrition encountered in this group were similar to their non-exposed counterparts. 
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4.10. Study limitations: 
The study protocol relied on the paediatric registrar on duty identifying participants and 
obtaining consent for study participation. Owing to their high workloads, study consent was not 
always a priority for registrars when caring for critically ill children and a number of eligible cases 
were missed. The researcher tried to obtain consent for including these “missed” children into the 
study at a later stage but the child’s caregiver was sometimes not available, and the child could then 
not be included into the study. Recognising that this might have significantly limited study 
enrolment, the researcher subsequently left consent forms in the patients’ files to be filled out by 
the attending doctor once the caregiver arrived for a visit. The researcher has no way of knowing 
how many cases may have been missed, but in his opinion these strategies limited the number of 
such children, and this did not affect the validity of the observations significantly. 
A comparison of patients identified using the WHO criteria and the Wellcome criteria could not 
be made because few patients were identified and enrolled for the study if they did not meet 
Wellcome criteria. This is probably because the WHO criteria are little known and seldom used in 
South African hospitals. Although this difficulty in enrolling patients who did not fulfil Wellcome 
criteria limits the study’s ability to assess the differences between the two definitions, this was not 
the study’s main objective. 
The information needed for the history section of the questionnaire was taken from the child’s 
bed-letter when the caregiver was not available, so this information could not be verified and was 
sometimes incomplete. This limited the amount of analysis that could be done on the history section 
of the questionnaire. But this was once again not one of the study’s main objectives. 
Owing to limited time and resources, only initial blood samples and their results were captured, 
while ward management decisions to start second line antibiotics, blood transfusions, etc. were 
captured over the entire stay. Of particular concern was the lack of documentation of tuberculin skin 
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test results. The result of this test was often not noted in the file or laboratory result sheet, and it 
was thus difficult to follow up its results. Although it may be reasonably assumed that a positive skin 
test result would have been noted in the file, no test was assumed to be negative if not specifically 
noted in the file or physically seen by the researcher. However, capturing this additional information 
would not have altered any of the results discussed above. 
Owing to the fact that the researcher could not physically visit every hospital every day, many 
files were not reviewed after the child’s discharge or transfer. However, the visits were timed so that 
no child would be missed for more than four consecutive days, hence limiting the extent of potential 
missed recording of interventions and events prior to discharge. All charts of children who died were 
reviewed by the researcher after the child’s demise. 
Ideally the study question required a long term follow-up study to document how many children 
reach the recommended discharge criteria of 90% of expected weight for height,(3) particularly as 
high incidences of mortality beyond the initial stabilisation phase have been described.(66) However 
this was not possible in the short period of time available for the research report. 
Finally, the sample size calculation as reported in section suggested a sample size of 318 
patients, which was difficult to achieve in a short period of data collection. The researcher was 
fortunate that a more limited sample size proved adequate. Given the observed mortality rates of 
3.9% and 19%, using a significance level α = 0.05 and the observed case: control ratio of 1:1, the 
power of the study was calculated to be 0.92. 
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4.11. Areas for future research: 
 The management of HIV in the face of severe malnutrition: the indications and timing of 
TB treatment, HAART and nutritional rehabilitation need further research to help 
generate appropriate guidelines. 
 The management of shock and severe anaemia in severely malnourished children: 
indications and recommendations for intravenous therapies need to be devised to 
address this remaining cause of mortality. 
 The safety of breastfeeding HIV exposed infants while mother or baby is on HAART 
needs more evidence: how low are the transmission rates and is there any toxicity from 
the baby’s exposure to antiretroviral drugs excreted in breast milk? 
 HIV negative but exposed children form a large group and they are vulnerable to 
excessive morbidity and mortality: their need for possible closer follow-up, socio-
economic and pharmacological interventions is an under-researched area.  
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5. Conclusion 
HIV was directly or indirectly responsible for most of the severe malnutrition seen in children 
admitted to the paediatric wards at the Johannesburg group of academic hospitals. The infection has 
changed the pathophysiology and mortality rates of malnutrition in Johannesburg. When evaluating 
the performance of an institution’s management of malnutrition, case fatality rates should be 
separated into what is achieved in HIV negative children, and positive children. While the WHO 
guidelines address how to manage the traditional nutrition-related malnutrition seen in the pre-HIV 
era, there is a dire need for new guidelines to assist in lowering the mortality rate in HIV positive 
malnourished children. 
Despite getting care in a relatively resource privileged setting, some basic steps in the 
management of malnutrition were not being practised consistently. There is a need for standardised 
protocols for all doctors in these hospitals to manage malnutrition. This may include the option of 
using the WHO definition for severe malnutrition and using mid-upper arm circumference 
measurements to broaden the net and to include more patients into the definition. Protocols will 
help to ensure that all those who qualify receive micronutrient supplements and measles vaccine, 
and to reinforce the use of broad spectrum antibiotics for all categories of children with severe 
malnutrition. 
Accurate measurement of length proved difficult in the admission ward setting. This can be 
extrapolated to mean that children visiting primary care clinics are probably also not measured 
accurately. It may thus be time to advocate for the more widespread use of mid-upper arm 
circumference measurements, which are easy to perform and to interpret.12 Its use may increase 
children’s opportunity to access the nutritional support they need. 
Tuberculosis is a common infection in malnourished children. The diagnosis of pulmonary 
tuberculosis disease remains difficult in children, and emphasis must be placed on an effective 
contact tracing, screening and prophylaxis programme.  
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Ultimately, intervention must be aimed at the prevention of malnutrition, and it seems there 
may be much that could be done to address this. Firstly, the growth monitoring and promotion 
programme needs strengthening through improved nutrition counselling, food supplementation and 
better referral systems. Secondly, breastfeeding must be promoted in all HIV negative mothers, and 
possibly also all positive mothers on antiretroviral treatment. Prevention of mother to child 
transmission of HIV programmes need expansion to ensure that all pregnant women have an 
opportunity to test for HIV and get appropriate antiretroviral therapy to diminish vertical 
transmission rates. If an infant is infected, early diagnosis and early antiretroviral treatment is the 
key to avoid a high risk of morbidity and mortality. Lastly, HIV affected children require more routine 
attention. This may include closer follow-up and monitoring, access to social services and financial 
aid where parents are ill or dead and possibly chemoprophylaxis to prevent common infections. 
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6. Recommendations 
 Monitoring of programme performance of in-patient management of severe 
malnutrition should address the case fatality rates of HIV positive and negative children 
separately. 
 Hospital protocols for the management of severe malnutrition are needed in the study 
setting. 
 There should be more widespread use of mid-upper arm circumference measurements 
to identify severely malnourished children. 
 The provincial tuberculosis contact tracing, screening and prophylaxis programme needs 
to be drastically improved. 
 Programmes aimed at preventing malnutrition such as the growth monitoring and 
promotion and PMTCT programmes require attention. 
 HIV affected children should be followed up as part of the prevention of mother to child 
transmission programme. They are a vulnerable group and may need more medical, 
social and financial assistance. This is a research priority. 
 Prevention of mother to child transmission programmes need to be expanded to ensure 
a lower transmission rate. The results of studies examining the safety and efficacy of 
breastfeeding while antiretroviral treatment is provided to the infant or mother are 
awaited with interest. The recently published feeding guidelines for HIV exposed infants 
from the World Health Organisation support this.(72) 
 Infants infected with HIV should be diagnosed early and started on antiretroviral 
treatment immediately to help prevent further morbidity and mortality, including 
malnutrition. 
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APPENDIX A - Data collection form 
Section 1: History 
 Personal details  
Snum Study number  
Dob Date of birth  
Sex Sex  
Pob Place of birth 1= Hospital 2= Clinic 3= Home 4= Other 5= Unknown 
Doa Date of arrival  
 
 Anthropometrics  
mr Measurements redone?         Yes              No, taken from file Z-scores 
Wt Weight (kg)   
Lt Length/Height (cm)   
HC Head circumference (cm)   
MUAC Mid upper arm circumference   
Oed Oedema       Yes              No Wt for Lt Z score  
Wast Severe visible wasting      Yes              No 
WHO WHO severe malnut       Yes              No 
Well Wellcome class 1= Normal 2= Under 3= Maras 4= Kwashi 5= Mar-Kw 
 
 HIV status – Child  
HIVe HIV exposed? 1= Yes 2= No 3= Unknown 
HIVp HIV PCR 1= Positive 2= Negative 3= Early Neg 4= Unknown 
PMC PMTCT given? 1= No 2= NVP 3= NVP + AZT 4= N/A 5= Unknown 
ARV On HAART      Yes              No 
ARVd Time on HAART                      Months 
CD4 CD4% prior to admission  VL Viral  load prior to admission  
 
 HIV status – Mom  
mARV Mom on HAART? 1= Yes 2= No 3= Unknown 4= N/A 5= Mom not around 
mARVd Time on HAART                             Months 
mPMC Received PMTCT? 1= No 2= NVP 3= AZT + 
NVP < 4/52 
4= AZT + 
NVP > 4/52 
5= N/A 6= Unknown 
mCD4 Last CD4  mVL Viral load  
mWHO WHO status  
 
 Main complaint 
Dia Diarrhoea (Y/N)      Yes              No dDia Duration  1=<1wk 2=1-2w 3= >2w 4= Unkn 
Vom Vomiting (Y/N)      Yes              No dVom Duration  1=<1wk 2=1-2w 3= >2w 4= Unkn 
Cou Cough (Y/N)      Yes              No dCou Duration  1=<1wk 2=1-2w 3= >2w 4= Unkn 
Fev Fever (Y/N)      Yes              No dFev Duration  1=<1wk 2=1-2w 3= >2w 4= Unkn 
oSx1 Other symptom  doSx1 Duration  1=<1wk 2=1-2w 3= >2w 4= Unkn 
oSx2 Other symptom  doSx2 Duration  1=<1wk 2=1-2w 3= >2w 4= Unkn 
oSx3 Other symptom  doSx2 Duration  1=<1wk 2=1-2w 3= >2w 4= Unkn 
TBc Close TB contact? 1= 
Yes 
2= 
No 
3= 
Unknown 
TBp TB 
prophylaxis  
1= 
Yes 
2= 
No 
3= 
Unknown 
Coad Adult with chronic cough in household?      Yes              No 
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Previous admissions 
pAdm Previously admitted?      Yes            No 
 
Medications and muthi in last week 
Med Recorded?      Yes            No 
Med1-5 1= ARV’s 2= TB Rx 3= TB proph 4= Bactrim 5= other a’bic 6= MVT 7= Fe 
Medo1-4 Other meds     
Muthi1-4 Muthi + other     
 
Road to Health card and immunisations 
RTHC RTHC seen      Yes            No 
Imm Immunisations 1= Up to date 2= Incomplete 3= Never immunised 4= Unknown 
 
Milestones    
Mile Milestones        Appropriate               Delayed 
 
Feeding    
BF Breastfeeding? 1= Yes, current 2= Yes, previously 3= Never 4= Unknown 
BFs If BF stopped, at what age?                                      Months 
FF Formula feeding? 1= Yes, current 2= Yes, previously 3= Never 4= Unknown 
FFs If stopped, at what age?                                      Months 
FP Formula preparation  1= Adequate 2= Inadequate 3= Unknown 
FPp Problems with formula prep 1= Too 
dilute 
2= Too 
strong 
3= Not 
hygienic 
4= Inadequate 
quantity 
5= Other: 
Sol Solids? 1= Yes 2= No 3= Unknown 
Sola Age of first solids                                      Months 
 
Social history  
Hous Housing 1= Brick house 2= Flat 3= Shack 4= Other 5= Unknown 
RW Running water  1= Yes inside/ in 
yard 
2= Yes on 
street 
3= No 4= Unknown 
FT Flushing toilet  1= Yes 2= No 3= Unknown 
Elec Electricity 1= Yes 2= No 3= Unknown 
Mcg Main caregiver 1= Mother 2= Father 3= Grandparent 4= Aunt 5= Other 
mal Mother alive 1= Yes 2= No 3= Unknown 
fal Father alive 1= Yes 2= No 3= Unknown 
Memp Mother employed 1= Yes 2= No 3= Unknown 4= Mother AWOL 
Femp Father employed 1= Yes 2= No 3= Unknown 4= Father AWOL 
CSG Child support 
grant 
1= Yes 2= No 3= Unknown 
Oinc Other 
income 
1= Other grants 2= Grandparents support 3= Piecework 4= Other 5= 
Unknown 
Bord Birth order  
Sibs Number of 
siblings 
 Sibd Siblings who died (No)  
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Section 2: Examination 
Vitals on admission   
HR Heart rate                  Bpm RR Resp rate                   Bpm 
Temp Temperature                        ̊C 
 
General – please tick     
Pale Pallor  Deh Dehydration   RDS Resp distress  
Jau Jaundice  Shk Shock   EDC Ear discharge  
hog Hypoglycaemia     NR Napkin rash  
Wder Weeping dermatitis  Ocan Oral candida  Pet Petechiae  
ASto Angular stomatitis  LAD Lymphadenopathy  Bru Bruising  
BdF Bulldog facies  HaC Hair changes  cul Corneal ulcers  
HoT Hypothermia  Hepa Hepatomegaly  Splen Splenomegaly  
 
Systems examination 
HMs Hepatomegaly size                Cm below ribs Spls Spleen size                             Cm below ribs 
OEo Other findings 
Section 3: Laboratory values on admisssion  
FBC WCC Hb MCV Plts 
U&E Na K CO2
 
Urea 
LFT SBR TP Alb CRP 
Other Glucose INR CD4 (%) CD4(abs) 
 VL CCa PO4 Mg 
Urine UTI       Yes            No Culture  Ucult  
Blood culture bcpos      Yes            No Organisms Org1-2   
Tuberculosis PPD 1= Pos 2= Neg 3= Not done AFB 1= Pos 2= Neg 3= Not done 
CSF Men      Yes            No Organism morg  
Other loth  
Section4: Management  
Rx given during hospital stay 
 Antibiotics –  
Tick all 
1= Ampi 2= Genta 3= Tazocin 4= Amik 5= Mero 6= Vanco 
7= Ceph 8= Clox 9= Bactrim 10= TB Rx 11= Other:  
hBTF Packed cell transfusion?      Yes            No 
hARV HAART      Yes            No 
hffp Fresh frozen plasma      Yes            No 
hMaln 
1-5 
Malnut regime etc:  
Tick all 
1= Mist KCl 2= Zinc 3= Vit A 4= Vit K 
5= MVT 6= Folate 7= Iron 8= Measles vaccine 
hOth1-3    
Section 5: Outcome 
Outc Outcome 1= Discharged home 2= Died 3= Transferred out 4= RHT 
dOut Date of outcome  dWt Weight  
dDx1 Other diagnoses  dHt Height   
dDx2 Other diagnoses  dOed Oedema      Yes            No 
dDx3 Other diagnoses    
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Section 6: Death & CHIP forms 
CoD1 Causes of death  
CoD2 Causes of death  
CoD3 Causes of death  
CHIP  CHIP form filled      Yes            No 
Avfac 
1-5 
Avoidable factors (list) 
 
 
 
Section 7: Additional comments 
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APPENDIX C – Gauteng Department of Health approval 
 
